211 related articles for article (PubMed ID: 31746515)
1. Circulating microRNAs as potential biomarkers for genetic generalized epilepsies: a three microRNA panel.
Martins-Ferreira R; Chaves J; Carvalho C; Bettencourt A; Chorão R; Freitas J; Samões R; Boleixa D; Lopes J; Ramalheira J; da Silva BM; Martins da Silva A; Costa PP; Leal B
Eur J Neurol; 2020 Apr; 27(4):660-666. PubMed ID: 31746515
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-146a-5p and miR-132-3p as potential diagnostic biomarkers in epilepsy.
Nomair AM; Mekky JF; El-Hamshary SA; Nomeir HM
Epilepsy Res; 2023 Mar; 191():107089. PubMed ID: 36801489
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum miR-106b and miR-146a in patients with focal and generalized epilepsy.
An N; Zhao W; Liu Y; Yang X; Chen P
Epilepsy Res; 2016 Nov; 127():311-316. PubMed ID: 27694013
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-146a and miR-134 in predicting drug-resistant epilepsy in patients with focal impaired awareness seizures.
Leontariti M; Avgeris M; Katsarou MS; Drakoulis N; Siatouni A; Verentzioti A; Alexoudi A; Fytraki A; Patrikelis P; Vassilacopoulou D; Gatzonis S; Sideris DC
Epilepsia; 2020 May; 61(5):959-970. PubMed ID: 32314378
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA: The Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy, a Pilot Study.
De Benedittis S; Fortunato F; Cava C; Gallivanone F; Iaccino E; Caligiuri ME; Castiglioni I; Bertoli G; Manna I; Labate A; Gambardella A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445780
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
10. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Chen W; Li S
Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
[TBL] [Abstract][Full Text] [Related]
14. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
[TBL] [Abstract][Full Text] [Related]
15. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
Al-Rawaf HA; Alghadir AH; Gabr SA
Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
[TBL] [Abstract][Full Text] [Related]
16. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer.
Zou JG; Ma LF; Li X; Xu FL; Fei XZ; Liu Q; Bai QL; Dong YL
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1108-1115. PubMed ID: 30779079
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects.
Gu H; Chen L; Xue J; Huang T; Wei X; Liu D; Ma W; Cao S; Yuan Z
Biomed Pharmacother; 2019 Jan; 109():823-830. PubMed ID: 30551536
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
20. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
